M E Lewis1, C Newall, J N Townend, S L Hill, R S Bonser. 1. Heart and Lung Transplantation Unit, Department of Cardiothoracic Surgery, Queen Elizabeth Hospital, University Hospital NHS Trust, Birmingham B15 2TH, UK.
Abstract
OBJECTIVE: To compare the incremental shuttle walk test (ISWT) with treadmill exercise testing (TT) derived measurement of peak oxygen consumption (peak VO(2)) in patients undergoing assessment for cardiac transplantation. DESIGN: Prospective comparison. All investigations occurred during a single period of admission for transplant assessment. SETTING: Single UK cardiothoracic transplantation unit. PATIENTS: 25 patients recruited (21 men). Mean age was 53 years. INTERVENTIONS: Patients underwent two TT of peak VO(2) using the modified Naughton protocol and three (one practice) ISWT. Investigations were performed on consecutive days. MAIN OUTCOME MEASURES: Main outcome measures were repeatability of TT and ISWT assessments; relation between peak VO(2) and distance walked in the ISWT; and receiver operating characteristic (ROC) analysis to establish a distance walked in the ISWT that predicted which patients would have a peak VO(2) greater than 14 ml/min/kg. RESULTS: Both the ISWT and the TT were highly reproducible. Following the first practice walk, mean (SD) ISWT distances were 400.0 (146) m (ISWT2) and 401.3 (129) m (ISWT3), r = 0.90, p < 0.0001. Mean peak VO(2) by TT was 15.2 (4.4) ml/kg/min (TT1) and 15.0 (4.4) ml/kg/min (TT2), r = 0.83, p < 0.0001. The results revealed a strong correlation between distance covered in the ISWT and peak VO(2) obtained during TT (r = 0.73, p = 0.0001). ROC analysis showed that a distance walked of 450 m allowed the selection of patients with a peak VO(2) of over 14 ml/min/kg. CONCLUSIONS: This work confirms the utility of the ISWT in the assessment of exercise capacity in patients with severe heart failure undergoing assessment for cardiac transplantation. ISWT may provide a widely applicable surrogate measure for peak VO(2) estimation in this population. Shuttle distance walked may therefore allow the convenient, serial assessment of patients with heart failure before referral for transplantation.
OBJECTIVE: To compare the incremental shuttle walk test (ISWT) with treadmill exercise testing (TT) derived measurement of peak oxygen consumption (peak VO(2)) in patients undergoing assessment for cardiac transplantation. DESIGN: Prospective comparison. All investigations occurred during a single period of admission for transplant assessment. SETTING: Single UK cardiothoracic transplantation unit. PATIENTS: 25 patients recruited (21 men). Mean age was 53 years. INTERVENTIONS:Patients underwent two TT of peak VO(2) using the modified Naughton protocol and three (one practice) ISWT. Investigations were performed on consecutive days. MAIN OUTCOME MEASURES: Main outcome measures were repeatability of TT and ISWT assessments; relation between peak VO(2) and distance walked in the ISWT; and receiver operating characteristic (ROC) analysis to establish a distance walked in the ISWT that predicted which patients would have a peak VO(2) greater than 14 ml/min/kg. RESULTS: Both the ISWT and the TT were highly reproducible. Following the first practice walk, mean (SD) ISWT distances were 400.0 (146) m (ISWT2) and 401.3 (129) m (ISWT3), r = 0.90, p < 0.0001. Mean peak VO(2) by TT was 15.2 (4.4) ml/kg/min (TT1) and 15.0 (4.4) ml/kg/min (TT2), r = 0.83, p < 0.0001. The results revealed a strong correlation between distance covered in the ISWT and peak VO(2) obtained during TT (r = 0.73, p = 0.0001). ROC analysis showed that a distance walked of 450 m allowed the selection of patients with a peak VO(2) of over 14 ml/min/kg. CONCLUSIONS: This work confirms the utility of the ISWT in the assessment of exercise capacity in patients with severe heart failure undergoing assessment for cardiac transplantation. ISWT may provide a widely applicable surrogate measure for peak VO(2) estimation in this population. Shuttle distance walked may therefore allow the convenient, serial assessment of patients with heart failure before referral for transplantation.
Authors: J Myers; N Buchanan; D Walsh; M Kraemer; P McAuley; M Hamilton-Wessler; V F Froelicher Journal: J Am Coll Cardiol Date: 1991-05 Impact factor: 24.094
Authors: F J Morales; A Martínez; M Méndez; A Agarrado; F Ortega; J Fernández-Guerra; T Montemayor; J Burgos Journal: Am Heart J Date: 1999-08 Impact factor: 4.749
Authors: L Y Herring; C Stevinson; P Carter; S J H Biddle; D Bowrey; C Sutton; M J Davies Journal: Int J Obes (Lond) Date: 2017-03-06 Impact factor: 5.095
Authors: Jin Hee Jeong; Annabel Biruete; Emily J Tomayko; Pei Tzu Wu; Peter Fitschen; Hae Ryong Chung; Mohamad Ali; Edward McAuley; Bo Fernhall; Shane A Phillips; Kenneth R Wilund Journal: Kidney Int Date: 2019-04-02 Impact factor: 10.612
Authors: Cristiane Pulz; Rosiane V Diniz; Alexandre N F Alves; Antônio S Tebexreni; Antônio C Carvalho; Angelo A V de Paola; Dirceu R Almeida Journal: Can J Cardiol Date: 2008-02 Impact factor: 5.223
Authors: Henrique Silveira Costa; Rafael Leite Alves; Stela Alves da Silva; Maria Clara Noman Alencar; Maria do Carmo Pereira Nunes; Márcia Maria Oliveria Lima; Manoel Otávio da Costa Rocha Journal: Int J Prev Med Date: 2014-02
Authors: Robert A Lewis; Catherine G Billings; Judith A Hurdman; Ian A Smith; Matthew Austin; Iain J Armstrong; Jennifer Middleton; Alexander M K Rothman; John Harrington; Neil Hamilton; Abdul G Hameed; A A Roger Thompson; Athanasios Charalampopoulos; Charlie A Elliot; Allan Lawrie; Ian Sabroe; Jim M Wild; Andrew J Swift; Robin Condliffe; David G Kiely Journal: Ann Am Thorac Soc Date: 2021-01